Latest Biotechnology, Pharmaceutical and Healthcare News

03:44 EDT 4th September 2015 | BioPortfolio

Showing News Articles 1–25 of 410,000+

Friday 4th September 2015

Overexpression of microRNA-133a inhibits ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting DAPK2

Hematopoietic knockdown of PPARδ reduces atherosclerosis in LDLR−/− mice

Development of operational immunologic tolerance with neonatal gene transfer in nonhuman primates: preliminary studies

Novartis receives EU approval for Farydak®, the first in its class of anticancer agents approved for patients with multiple myeloma

Novartis International AG / Novartis receives EU approval for Farydak®, the first in its class of anticancer agents approved for patients with multiple myeloma . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Farydak (panobinostat) combination is approved in the EU for patients with multiple myel...

Melanoma Risk and Survival among Organ Transplant Recipients

BioBots to Debut Desktop 3D Bioprinter for Living Tissue at TERMIS Global Tissue Engineering Conference in Boston

University of Pennsylvania-founded bioprinting startup, BioBots will debut its production desktop 3D printer, capable of printing functional 3D constructs from living cells, to a worldwide collective of leading researchers and clinicians in the fields of tissue engineering and regenerative medicine at the tri-annual TERMIS World Congress in Boston, MA on September 8th. Boston, MA (PRWEB) September...

Kolibree’s Sonic Toothbrush Gets Dentist Approval; Connected Families Build Better Oral Hygiene Habits

Children who used the Kolibree sonic toothbrush with the Go Pirate game on the Kolibree app reduced plaque more effectively than those who brushed with a manual or rotary electric toothbrush, according to an informal pilot study involving children between the ages of 5 and 14. This pilot study concluded that Kolibree seems to engage children to complete a full two minutes of brushing without coaxi...

November Research Group’s PRIMO Mobile Goes Live at Allergan Japan

Mobile AE Intake Solution Introduced to Allergan’s Medical Representatives San Francisco, CA (PRWEB) September 04, 2015 November Research Group, LLC, a global leader in the delivery of product safety and pharmacovigilance services and software tools to pharmaceutical and life sciences organizations, today announced the production implementation of its new software application, PRIMO Mobile by A...

Health Food Emporium Announces Back to School Sale on Multivitamins for Moms and Kids

Health Food Emporium is having a sale on multivitamins, probiotics and Omega 3s for Moms and Kids to support healthy immune systems as children head back to school this month. (PRWEB) September 04, 2015 A recent article by CNN stated, "On average, elementary school children get eight to 12 colds or cases of the flu each school year, according to the CDC. For the older kids, it is about half ...

Cincinnati Divorce Attorney Mark Eppley, Family First Law, Announces Partnership with Cornetet, Meyer, Rush & Kirzner

After 10 years in private practice at Family First, Attorney Mark Eppley has joined the firm of Cornetet, Meyer, Rush and Kirzner. With a passion for families, Eppley is best known for his focused approach towards families with children. Cincinnati, OH (PRWEB) September 04, 2015 After 10 years in private practice at Family First, Attorney Mark Eppley has joined the firm of Cornetet, Meyer, Rush a...

Imagination Playground Announces Extension to Build-A-Thon

Imagination Playground, LLC, http://www.imaginationplayground.com, creators of the breakthrough play space concept that encourages child-directed, unstructured free play, announced today the extension of their Build-A-Thon contest through December 18, 2015. The contest winners, over 500 in all, will be announced on January 5, 2016. New York, New York (PRWEB) September 04, 2015 Imagination Playgro...

Cortendo plc Announces Provisional Results of Exchange Offer to Acquire Shares of Cortendo AB (Publ)

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OF INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (THE "UNITED STATES") (INCLUDING ITS TERRITORIES AND POSSESSIONS), ANY STATE OF THE UNITED STATES OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. Cortendo plc today announced the provisi...

China Generic Drugmakers Poaching Indian Execs

In the competition between China and India pharmas, China's generic drug industry leads in the supply of APIs to global drugmakers, but India supplies more finished generic drugs to the world's marketplace. That may be changing. According to press re...

CFDA is Hiring Drug Reviewers

The China Food and Drug Administration is making good on its promise to speed up the drug approval process: it has posted a notice seeking to recruit an additional 69 people to review drug approval submissions. If they all are hired, it would represe...

BRIEF-Photocure announces marketing authorization application for Hexvix in Australia

* Announces submission of application for Hexvix marketing authorization in Australia by its partner and exclusive distributor, Juno Pharmaceuticals

Bayer says to launch Covestro IPO with new shares only

FRANKFURT, Sept 4 (Reuters) - Bayer's Covestro, Europe's fourth-largest chemicals maker, will launch an intital public offering of new shares in the fourth quarter, Bayer said on Friday.

Weifa ASA: Call for Extraordinary General Meeting

Weifa ASA (OSE: WEIFA) please find attached the call for Extraordinary General Meeting in Weifa ASA to be held on 25 September at 15:00 CET, at Østensjoeveien 27, Oslo. The formal call for the Ext...

Swiss stocks - Factors to watch on Sept 4

ZURICH, Sept 4 (Reuters) - The Swiss blue-chip SMI was seen opening 0.8 percent lower at 8,703 points on Friday, according to premarket indications by bank Julius Baer .

BRIEF-Astrazeneca says US FDA approves expanded indication for brilinta

* Announces that US Food And Drug Administration (FDA) has approved brilinta  (ticagrelor) tablets at a new 60mg dose to be used in patients with a history of heart attack beyond first year

Guten Morgen mit BASF, Gazprom, Commerzbank, Deutsche Börse, HanseYachts, Henkel, Software AG und Roche

BASBASF und Gazprom vereinbaren Vollzug des Asset-Tauschs CBKCommerzbank: Risikovorstand Schmittmann scheidet zum Jahresende aus DB1 (VB -2,0%)Deutsche Börse beschafft sich durch Aktien-Verkauf 200...

Novartis Gets EU Approval For Farydak In Patients With Multiple Myeloma

BASEL (dpa-AFX) - Swiss drugmaker Novartis (NVS) said the European Commission has approved Farydak (panobinostat, previously known as LBH589) capsules, in combination with bortezomib and dexametha...

BRIEF-Cerenis Therapeutics announces publication in PLOS ONE revue

* Announces that positive preclinical in vitro and in vivo results, evaluating its ABCA1 acting as the dose of CER-001 or natural HDL particles have been published in the international scientific journal PLOS ONE Source text for Eikon: Further compan...

Novartis-Medikament Farydak erhält Zulassung von EU-Kommission

Basel/Brüssel (awp) - Novartis hat von der EU-Kommission eine Zulassung für das Medikament Farydak für die Therapie von Patienten mit bereits behandeltem Knochenmark-Krebs (multiples Myelom). Die Z...

Roche erhält von FDA "breakthrough therapy"-Status für ACE910 bei Hämophilie A

Basel (awp) - Der Pharmakonzern Roche hat für sein Prüfmedikament ACE910 von der amerikanischen Gesundheitsbehörde FDA den Status "Therapiedurchbruch" (Breakthrough therapy designation) bei der Beh...

BRIEF-Novartis AG says receives EU approval for Farydak

* Says receives EU approval for Farydak Source text for Eikon: [C:\Users\g195632\AppData\Local\Fastwire\Download\935257\Body.Ht ml] Further company coverage: (Reporting By Zurich Slot)



Advertisement
 
Advertisement
 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.